Drugs & medicalClass II

Fresenius Kabi USA, LLC recalls Naropin (ropivacaine hydrochloride Injection, USP), 0.5%, 100 mg per 20 mL (5 mg per mL), Twenty-five, 20 mL Single-Dose Vials, Rx only,…

Presence of Particulate Matter: Hair was found in products

Read the official notice →
Date
2026-07-29
Country
United States
Brand
Fresenius Kabi
Product
Naropin (ropivacaine hydrochloride Injection, USP), 0.5%, 100 mg per 20 mL (5 mg per mL), Twenty-five, 20 mL Single-Dose Vials, Rx only,…
Classification
Class II
Units
Nationwide within in the USA
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Fresenius Kabi recalls

  1. 2026-09-02
  2. US
    Drugs & medicalClass I

    Fresenius Kabi USA, LLC recalls Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by Fresenius Kabi USA, LLC, Lake Zurich,…

    Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles.

    FDA · DrugFresenius Kabi USA, LLCNationwide in the USAOfficial notice →
  3. 2026-08-26
  4. US
    Drugs & medicalClass I

    Fresenius Kabi USA, LLC recalls Morphine Sulfate Injection, USP, 2 mg /mL, 1 mL single-dose Simplist prefilled syringes, For Intramuscular or Intravenous use, Rx only,…

    Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.

    FDA · DrugFresenius Kabi USA, LLCNationwide within the USA.Official notice →
  5. 2026-07-29
  6. US
    Drugs & medicalClass II

    Fresenius Kabi USA, LLC recalls Glycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x 5 mL fill in a 6.5 mL vial, Rx only, Multiple Dose Vials, Fresenius…

    Presence of Particulate Matter: Hair was found in product

    FDA · DrugFresenius Kabi USA, LLCNationwide within in the USAOfficial notice →
  7. 2026-06-17
  8. US
  9. 2026-06-10
  10. US
    Drugs & medicalClass II

    Fresenius Kabi USA, LLC recalls The Large Volume Pump (LVP) of the Ivenix Infusion System (IIS). Model Number: LVP-0004.

    Potential for the Cassette Loading Lever to break.

    FDA · DeviceFresenius Kabi USA, LLCUS Nationwide distribution in the states of CA, CO, FL, GA, ID, IL, MA, MD,…Official notice →
  11. US
    Drugs & medicalClass I

    Fresenius Kabi USA, LLC recalls Ivenix Infusion System (IIS), Large Volume Pump, Model Number: LVP-0004

    Fresenius Kabi has been made aware via customer complaints that dropping or severe jarring of the Ivenix LVP may cause damage to internal components that may not be apparent or readily visible and the devices therefore…

    FDA · DeviceFresenius Kabi USA, LLCDomestic: CA, CO, FL, GA, ID, IL, MD, MI, MI , MN, MO, MS, NE, NJ, NV, OK, OR,…Official notice →
All 31 Fresenius Kabi recalls →

Other drugs & medical recalls in the United States

  1. 2026-07-29
  2. US
  3. US
    Drugs & medicalClass III

    Ascend Laboratories, LLC recalls Dabigatran etexilate Capsules, 150 mg, 20-count carton (2x10), Rx only, Manufactured by: Alkem Laboratories, Mumbai, INDIA, Distributed…

    Failed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and Total impurity testing for 12 Month Long-Term Stability.

    FDA · DrugAscend Laboratories, LLCUSA NationwideOfficial notice →
  4. US
    Drugs & medicalClass I

    JB Chemicals and Pharmaceuticals Ltd recalls Cetirizine Hydrochloride Tablets USP 5 mg, 100-count bottle, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B.…

    Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg. Determined to be Ranitidine.

    FDA · DrugJB Chemicals and Pharmaceuticals LtdNationwide in the USAOfficial notice →
  5. US
    Drugs & medicalClass II

    Fresenius Kabi USA, LLC recalls Glycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x 5 mL fill in a 6.5 mL vial, Rx only, Multiple Dose Vials, Fresenius…

    Presence of Particulate Matter: Hair was found in product

    FDA · DrugFresenius Kabi USA, LLCNationwide within in the USAOfficial notice →
  6. US
    Drugs & medicalClass II

    Rising Pharma Holding, Inc. recalls Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufactured for: Rising Pharma Holdings, Inc.,…

    Presence of Precipitate: medication was crystallizing and particles floating in the bottle

    FDA · DrugRising Pharma Holding, Inc.Nationwide U.S.A.Official notice →
  7. US
    Drugs & medicalClass II

    Rohto-Mentholatum (Vietnam) Co., Ltd. recalls Rohto Cooling Eye Drops Max Strength (naphazoline hydrochloride 0.03%, polysorbate 90, 0.2%), Sterile 0.4 FL OZ (13 mL),…

    Lack of Assurance of Sterility

    FDA · DrugRohto-Mentholatum (Vietnam) Co., Ltd.Nationwide within the United StatesOfficial notice →
See all drugs & medical recalls →